Health

The Trump administration faces criticism from anti-abortion advocates for its failure to restrict access to mifepristone, a drug used for pregnancy termination, as the Supreme Court prepares to address the issue.

Black women face intimate partner violence at a significantly higher rate, with four in ten reporting abuse in their lifetimes. Experts assert that the moment of departure from an abusive relationship is the most perilous, necessitating a strategic, safety-focused exit plan for survival, especially given the weakened safety net and fewer resources available to Black women.

New York City Mayor Zorhan Mamdani has announced a $20 million investment to enhance childhood asthma treatment for families in the Bronx, a borough significantly impacted by high rates of asthma-related emergency room visits. Funded by the Metropolitan Transportation Authority’s congestion pricing plan, this initiative aims to address environmental justice concerns and improve public health outcomes for children in areas like Mott Haven, often referred to as 'Asthma Alley'.

Autistic youth are at higher risk for mental health struggles due to gaps in care, awareness and research, with 70% of individuals diagnosed with autism spectrum disorder having at least one co-occurring mental health condition, most commonly anxiety disorders and depression.

Dr. Pierre Johnson, a Black OB-GYN and surgeon, has made history by successfully removing a 27-pound fibroid from a pregnant patient—a procedure other medical professionals deemed too risky without terminating the pregnancy—earning him the moniker 'Fibroid Slayer' and highlighting his commitment to addressing medical bias and systemic health disparities affecting Black women through both surgical innovation and social media advocacy.

Despite decades of progress in HIV/AIDS treatment and prevention, young Black individuals continue to face disproportionately high rates of new infections. This ongoing crisis is fueled by shame, stigma, and silence, prompting healthcare providers, advocates, and local public health departments to unite in efforts to underscore HIV's continued prevalence and gravity among youth.

The U.S. Food and Drug Administration (FDA) has advanced the development of psychedelic-based mental health treatments by issuing national priority vouchers to three companies. These vouchers aim to fast-track the review process for psilocybin, intended for depression, and methylone, for post-traumatic stress disorder. Concurrently, the FDA has authorized an early-phase clinical study for ibogaine as a potential treatment for alcohol use disorder, marking the first U.S. clinical trial for the substance.

Karex, the world's largest condom manufacturer, has indicated that ongoing disruptions to global supply chains, intensified by the Iran war, could lead to a 20-30% price increase for its products.

Chronic stress has been linked to compromised male fertility, manifesting as lower sperm count and reduced sperm motility. This impact is frequently compounded by associated lifestyle factors, including inadequate sleep, weight gain, and increased substance use.

Significant findings from a new study underscore the efficacy of the human papillomavirus (HPV) vaccine, demonstrating a 46% reduction in the risk of HPV-related cancers for vaccinated boys and young men. This development reinforces public health recommendations for routine vaccination of preteens aged 11 or 12, with catch-up vaccinations advised for individuals up to age 26.